Limited Partnership VIII Horowitz serves as Executive at Tarsus Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Limited Partnership VIII Horowitz has executed 7 insider transactions totaling $3.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 20, 2020 involved exercising options for 71,427 shares valued at $0.
Limited Partnership VIII Horowitz currently holds 1,752,183 shares of Tarsus Pharmaceuticals, Inc. (TARS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Limited Partnership VIII Horowitz has been a net buyer of TARS stock. They have purchased $3.0M and sold $0 worth of shares.
Limited Partnership VIII Horowitz's most recent insider trade was on Oct 20, 2020, when they sold 71,427 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 20, 2020 | TARS | $0 | Conversion | 245,966 | $N/A | Discretionary |
| Oct 20, 2020 | TARS | $250.0K | Purchase | 15,625 | $16.00 | Discretionary |
| Oct 20, 2020 | TARS | $0 | Conversion | 7,396 | $N/A | Discretionary |
| Oct 20, 2020 | TARS | $2.7M | Purchase | 168,750 | $16.00 | Discretionary |
| Oct 20, 2020 | TARS | $0 | Conversion | 43,151 | $N/A | Discretionary |